Hubei Biocause Heilen Pharmaceutical Co. Ltd. Cash Flow Quality Index
Hubei Biocause Heilen Pharmaceutical Co. Ltd. cash flow quality index. Hubei Biocause Heilen Pharmaceutical Co. Ltd. (301211) has a Cash Flow Quality Index of 4.85x as of September 2025. Operating cash flow of CN¥11.57 Million exceeds net income of CN¥2.39 Million, indicating high earnings quality where cash backs reported profits. See how financially flexible is Hubei Biocause Heilen Pharmaceutical Co. to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Hubei Biocause Heilen Pharmaceutical Co. Ltd. (2017–2025)
Cash flow quality index of Hubei Biocause Heilen Pharmaceutical Co. Ltd. from 2017 to 2025. Historical Cash Flow Quality Index for Hubei Biocause Heilen Pharmaceutical Co. Ltd. across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Hubei Biocause Heilen Pharmaceutical Co. debt service capacity to assess how comfortably operating cash covers total debt obligations.
Hubei Biocause Heilen Pharmaceutical Co. Ltd. Cash Flow Quality Index by Year (2017–2025)
Hubei Biocause Heilen Pharmaceutical Co. Ltd. cash flow quality index by year from 2017 to 2025. Year-by-year earnings quality comparison for Hubei Biocause Heilen Pharmaceutical Co. Ltd.. For the full cash flow conversion analysis, see Hubei Biocause Heilen Pharmaceutical Co. operating cash flow efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | CN¥7.55 Million | CN¥34.91 Million | ▼ -79.4% |
| 2024 | 1.05x | CN¥96.07 Million | CN¥91.55 Million | ▲ +34.8% |
| 2023 | 0.78x | CN¥137.06 Million | CN¥176.12 Million | ▼ -61.0% |
| 2022 | 1.99x | CN¥250.79 Million | CN¥125.72 Million | ▲ +95.7% |
| 2021 | 1.02x | CN¥123.98 Million | CN¥121.65 Million | ▲ +40.8% |
| 2020 | 0.72x | CN¥121.67 Million | CN¥168.07 Million | ▼ -64.1% |
| 2019 | 2.02x | CN¥372.33 Million | CN¥184.62 Million | ▲ +142.2% |
| 2018 | 0.83x | CN¥76.18 Million | CN¥91.48 Million | ▲ +130.3% |
| 2017 | -2.75x | CN¥-65.44 Million | CN¥23.77 Million | — |